Reflections from news and commentary of the day
Subscribe To
Posts
Comments
Monday, November 22, 2021
ACS Risk Biomarkers Significantly Increase After mRNA COVID-19 Vaccine - The Cardiology Advisor
ACS Risk Biomarkers Significantly Increase After mRNA COVID-19 Vaccine - The Cardiology Advisor: A report presented at AHA 2021 finds that the PULS 5-year risk score for new ACS increases from 11% to 25% after mRNA COVID-19 vaccination.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment